Perspective Therapeutics, Inc. Income Statement
CATX|10 years of annual SEC 10-K data (FY2013-FY2022)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 10 fiscal years. All figures from audited SEC 10-K filings.
Perspective Therapeutics, Inc. reported $3M in revenue and $7M in net loss for FY2022. Revenue has declined at a 6.0% compound annual rate over the past 9 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 5.43 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.9M | $2.4M | $2.3M | $1.6M | $4.8M | $4.6M | $4.2M | $4.5M | $4.5M | $5.1M |
| Cost of Revenue | $6.2M | $4.3M | $4.1M | $3.9M | $4.6M | $4.4M | $4.4M | $4.4M | $4.4M | $4.4M |
| Gross Profit | $0 | $3.0M | $1.8M | $838.0K | $129.0K | $167.0K | -$196.5K | $150.2K | $150.2K | $703.2K |
| SG&A Expense | $5.6M | $4.2M | $4.2M | $3.9M | $3.8M | $2.4M | $2.5M | $2.3M | $2.3M | $2.4M |
| R&D Expense | $850.0K | $1.5M | $1.7M | $965.0K | $528.0K | $615.0K | $668.8K | $627.1K | $627.1K | $780.6K |
| Operating Income | -$6.4M | -$5.3M | -$6.7M | -$6.3M | -$5.1M | -$4.3M | -$4.6M | -$4.1M | -$4.1M | -$3.6M |
| Interest Expense | $0 | - | - | - | $1.0K | $2.0K | $883 | $7 | - | - |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | - | - | - |
| Net Income | -$7.3M | -$5.1M | -$6.7M | -$6.2M | -$4.7M | -$3.7M | -$6.0M | -$3.9M | -$3.9M | -$3.5M |
| EPS (Basic) | -$0.05 | - | - | - | - | - | - | - | - | - |
| EPS (Diluted) | - | -$0.08 | -$0.12 | -$0.11 | -$0.09 | -$0.07 | -$0.16 | -$0.11 | -$0.11 | -$0.12 |
| Shares Outstanding | 141.9M | 68.9M | 67.4M | 56.3M | 55.0M | 55.0M | 41.5M | 41.5M | 34.6M | 31.0M |
| Gross Margin | 0.0% | 127.8% | 79.6% | 53.6% | 2.7% | 3.6% | -4.7% | 3.3% | 3.3% | 13.9% |
| Operating Margin | -220.6% | -220.4% | -290.7% | -403.8% | -106.6% | -94.2% | -108.7% | -89.9% | -89.9% | -71.0% |
| Profit Margin | -249.9% | -215.8% | -289.4% | -394.5% | -98.8% | -79.9% | -141.2% | -85.2% | -85.2% | -68.8% |